Intellia Therapeutics, Inc. (NTLA) vs Zenas BioPharma, Inc. (ZBIO)
Intellia Therapeutics, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Zenas BioPharma, Inc. are of similar size ($1.8B and $1.7B). Zenas BioPharma, Inc. has the higher net margin (0.00% vs −672.2%) and the higher return on invested capital (0.00% vs −91.3%). Across the 13 metrics below, Zenas BioPharma, Inc. leads on 8 and Intellia Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | NTLA | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (711.66%) | 0.00% | 0.00% |
| Net margin | (672.16%) | 0.00% | 0.00% |
| Free cash flow margin | (585.82%) | 0.00% | 0.00% |
| Return on equity | (55.44%) | (199.04%) | (57.72%) |
| Return on assets | (45.55%) | (97.39%) | (49.22%) |
| Return on invested capital | (91.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack